KRIYA GENE THERAPY Trademark

Trademark Overview


On Tuesday, January 11, 2022, a trademark application was filed for KRIYA GENE THERAPY with the United States Patent and Trademark Office. The USPTO has given the KRIYA GENE THERAPY trademark a serial number of 97213542. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, April 29, 2024. This trademark is owned by Kriya Therapeutics, Inc.. The KRIYA GENE THERAPY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; biochemical preparations for use in medical industry, namely, biochemical preparations for the treatment of ophthalmic-related diseases

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders
kriya gene therapy

General Information


Serial Number97213542
Word MarkKRIYA GENE THERAPY
Filing DateTuesday, January 11, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, April 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; biochemical preparations for use in medical industry, namely, biochemical preparations for the treatment of ophthalmic-related diseases
NOT AVAILABLE"GENE THERAPY"
Goods and ServicesTesting, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 19, 2022
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 19, 2022
Primary Code042
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameKriya Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorrisville, US 27560

Party NameKriya Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, US 94306

Trademark Events


Event DateEvent Description
Friday, January 14, 2022NEW APPLICATION ENTERED
Wednesday, January 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 21, 2022ASSIGNED TO EXAMINER
Tuesday, August 2, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 2, 2022NON-FINAL ACTION E-MAILED
Tuesday, August 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 1, 2023ASSIGNED TO EXAMINER
Thursday, February 2, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, February 2, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, February 2, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 2, 2023ASSIGNED TO LIE
Thursday, February 2, 2023EXAMINER'S AMENDMENT ENTERED
Saturday, February 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 9, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 6, 2023SOU EXTENSION 1 GRANTED
Monday, November 6, 2023SOU EXTENSION 1 FILED
Wednesday, April 3, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 1, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, April 3, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 29, 2024SOU EXTENSION 2 FILED
Monday, April 29, 2024SOU EXTENSION 2 GRANTED